Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Zimran

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|October 21, 2011
Velaglucerase alfa: a new option for Gaucher disease treatmentA Zimran
Harefuah|June 16, 1991
[Progress and problems in the study of red cell aging]A Zimran
Harefuah|June 15, 1994
[Enzyme replacement therapy for Gaucher's disease]A Zimran, A Abrahamov
Israel Journal of Medical Sciences|August 1, 1995
Recent advances in diagnosis and therapy in Gaucher's diseaseD Elstein, A Zimran
Human Mutation|January 1, 1994
Mutations causing Gaucher diseaseM Horowitz, A Zimran
Chest|June 20, 2000
IV epoprostenol in Gaucher's diseaseD Elstein, A Zimran
American Journal of Medical Genetics|March 1, 1994
RecTL: a complex allele of the glucocerebrosidase gene associated with a mild clinical course of Gaucher diseaseA Zimran, M Horowitz
The American Journal of Clinical Nutrition|May 1, 1983
The changing pattern of megaloblastic anemia: megaloblastic anemia in IsraelA Zimran, C Hershko
American Journal of Ophthalmology|December 15, 1987
Can the risk of acetazolamide-induced aplastic anemia be decreased by periodic monitoring of blood cell counts?A Zimran, E Beutler
Bailliere'S Clinical Haematology|March 14, 1998
Gaucher's disease: genetic counselling and population screeningE Levy-Lahad, A Zimran
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Drugs of Today (Barcelona, Spain : 1998)|October 21, 2011
Velaglucerase alfa: a new option for Gaucher disease treatmentA Zimran
Harefuah|June 16, 1991
[Progress and problems in the study of red cell aging]A Zimran
Harefuah|June 15, 1994
[Enzyme replacement therapy for Gaucher's disease]A Zimran, A Abrahamov
Israel Journal of Medical Sciences|August 1, 1995
Recent advances in diagnosis and therapy in Gaucher's diseaseD Elstein, A Zimran
Human Mutation|January 1, 1994
Mutations causing Gaucher diseaseM Horowitz, A Zimran
Chest|June 20, 2000
IV epoprostenol in Gaucher's diseaseD Elstein, A Zimran
American Journal of Medical Genetics|March 1, 1994
RecTL: a complex allele of the glucocerebrosidase gene associated with a mild clinical course of Gaucher diseaseA Zimran, M Horowitz
The American Journal of Clinical Nutrition|May 1, 1983
The changing pattern of megaloblastic anemia: megaloblastic anemia in IsraelA Zimran, C Hershko
American Journal of Ophthalmology|December 15, 1987
Can the risk of acetazolamide-induced aplastic anemia be decreased by periodic monitoring of blood cell counts?A Zimran, E Beutler
Bailliere'S Clinical Haematology|March 14, 1998
Gaucher's disease: genetic counselling and population screeningE Levy-Lahad, A Zimran
Pageof 14